论文部分内容阅读
22例接受BCG 免疫治疗的恶性黑色素瘤(恶黑)患者在死后尸检中发现6例(29%)病人于不同器官(肺、脾、骨髓)有肉芽肿。对照组中25例未用BCG免疫治疗的恶黑患者尸检未发现肉芽肿。两组之间有统计学意义(P=0.006)。这说明了出现肉芽肿与BCG 免疫治疗有关。
Twenty-two patients with malignant melanoma (bad black) who received BCG immunotherapy were found postmortem autopsy. Six patients (29%) had granulomas in different organs (lung, spleen, and bone marrow). Twenty-five patients in the control group who were not treated with BCG immunotherapy did not find granulomas at autopsy. There was a statistically significant difference between the two groups (P=0.006). This shows that granulomas have been associated with BCG immunotherapy.